ArticleFrontiers in pharmacology2026
Risk stratification-based tiered medication therapy management for outpatients with asthma: a practical prospective study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore a new model of tiered medication therapy management (MTM) services for outpatients with bronchial asthma and evaluate its effectiveness. Methods: A new model of tiered MTM services for outpatients with asthma (referred to as the T-MTM model) was established based on the triangle risk stratification model, and its multidimensional value was evaluated using the ECHO model. A single-center, prospective, randomized controlled, open-label study was conducted. A total of 126 asthma patients who visited the Medication Therapy Clinic at Hebei Provincial People's Hospital from January 2024 to December 2024 were selected and randomly divided into an observation group and a control group, with 63 patients in each group. Patients in the observation group received T-MTM services, while those in the control group received traditional MTM services. The differences in values across the three dimensions-economic, clinical, and humanistic-were compared between the two groups before and after the intervention. Results: Before the intervention, there were no statistically significant differences in any indicators between the two groups ( Conclusion: Risk-stratified tiered MTM services enable pharmacists to rapidly identify high-risk asthma patients, significantly improve work efficiency and service volume, and simultaneously enhance patients' self-management capabilities. This approach provides evidence-based guidance for optimizing and tiering outpatient asthma pharmacy service resources and represents a modified pharmacy service model worthy of promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.